Biotech Values

[DewDiligence]

…the error is in following normal process in a health emergency.

That’s my view too.

I would submit that the PFE and MRNA applications constituted the most compelling datasets ever reviewed by the FDA—in any indication. EUAs should have been granted within a couple of days of the submissions, IMO.